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Introduction
An increasing number of patients with combined immu-
nodeficiencies have been found to carry hypomorphic
variants of genes that otherwise cause severe combined
immunodeficiency (SCID). These patients not only
present with recurrent and sometimes life-threatening
infections, but also with immunodysregulatory symp-
toms such as autoimmune cytopenias and granulomas,
and are a diagnostic challenge.
Objectives
The objective of this study was to determine whether
TRECs and KRECs are useful in identifying patients
beyond infancy with combined T- and B-cell deficiencies
who are otherwise difficult to diagnose due to late-onset,
heterogeneous clinical phenotypes and variable numbers
and functions of T and B cells.
Methods
Patients with combined immunodeficiency due to hRAG
mutations (n = 6), with DOCK8 deficiency (n = 3) and
with classical SCID due to RAG1, RAG2, ARTEMIS and
IL2RG defects were treated at the University Hospital
Ulm, Germany. Four of the patients with hRAG defi-
ciencies presented with granulomatous lesions, one with
vitiligo, three patients had autoimmune cytopenias. The
earliest available samples of MNCs were analyzed (cells
cryopreserved at the median age of 10 years, range 6-17
years) for patients with hRAG and DOCK-8 deficiencies.
Results
Immunophenotyping of hRAG patients’ peripheral
MNCs showed reduced, but variable numbers of T and
B cells. Thymic derived naïve CD3+CD45RA+ T cells
were < 30% in all patients (range 1-27%). Residual T-cell
function (proliferation assays) and B-cell function (anti-
body titres following vaccination, data not shown) were
detectable, but abnormal in all hRAG patients. T-cell
repertoires were diverse in 5 patients, and restricted in
patients 1 and 4. Even when detectable, TREC and
KREC amounts in hRAG patients were at least 32-fold
reduced compared to healthy controls
Conclusion
Measurement of TREC and KREC levels is a fast and
easily performed tool for the quantification of thymic
output and B-cell maturation respectively. We envisage
that these biomarkers may serve as valuable comple-
mentary parameters for the initial immunological
work-up when a diagnosis of CID is being considered.
Timely clinical suspicion paired with abnormal TREC
and KREC levels might facilitate earlier referral of this
group of patients with atypical and late presentation of
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